PAREXEL International to Participate in Evercore ISI MedTools Conference
November 16 2016 - 9:00AM
Business Wire
PAREXEL International Corporation (NASDAQ: PRXL) announced today
that it will be attending the Evercore ISI MedTools Conference in
Boston. Josef von Rickenbach, Chairman and Chief Executive Officer,
will participate on Wednesday, November 30, 2016.
About PAREXEL InternationalPAREXEL International
Corporation is a leading global biopharmaceutical services company,
providing a broad range of expertise-based clinical research,
consulting, medical communications, and technology solutions and
services to the worldwide pharmaceutical, biotechnology and medical
device industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to
clinical pharmacology, clinical trials management, and
reimbursement. PAREXEL Informatics provides advanced technology
solutions, including medical imaging, to facilitate the clinical
development process. Headquartered near Boston, Massachusetts,
PAREXEL has offices in 85 locations in 51 countries around the
world, and had approximately 18,750 employees in the first quarter.
For more information about PAREXEL International visit
www.PAREXEL.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161116005233/en/
PAREXEL International CorporationRonald AldridgeEmail:
Ron.Aldridge@PAREXEL.comTel.: + 1-781-434-4753 or
+1-781-434-8465
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Sep 2023 to Sep 2024